drugset / Trial / NCT01594099

Concurrent Chemoradiotherapy for Cervical Cancer in Elderly Women

NCT01594099 ↗

Phase 2 Unknown 45 enrolled Xi'an Jiaotong University
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the efficiency and safety of weekly Cisplatin /Liposome paclitaxel concurrent chemoradiothrapy in the treatment of locally advanced cervical cancer in elderly women.

Timeline

Start
2012-04
Primary completion
2013-10
Completion
2014-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified 20 mg —
Subject Paclitaxel Small molecule 40 mg/m2 —

Indications